Smilow Cancer Hospital celebrates 10th anniversary
Smilow Cancer Hospital at Yale New Haven celebrates 10 years since it opened its doors to a new state-of-the-art inpatient and outpatient 500,000-square-foot cancer care facility. Since that day in October 2009, Smilow Cancer Hospital and Yale Cancer Center have risen to the top echelon as one of the nation’s comprehensive cancer research and care facilities, providing advanced care to patients and families and pioneering cancer research.
Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy
One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients with certain blood cancers who have run out of treatment options. In Connecticut, the treatment is only available at Smilow Cancer Hospital in partnership with Yale Cancer Center.
Yale doctor helps highlight for worldwide focus on ‘silent killers’
In today’s world, non-communicable diseases (NCDs) such as cancers, heart and respiratory disease, diabetes, and Alzheimer’s — to name just a few — have quietly emerged as a pandemic of silent killers to collectively become the leading cause of death worldwide. Overall according to the World Health Organization (WHO), NCDs are responsible for more than 38 million deaths a year — more than all other causes combined.
One in three young adults has ridden with an impaired driver
One-third of young adults aged 19 and 20 report riding in a motor vehicle with an impaired driver at the wheel at least once in the past year, according to a new study co-authored by Yale researcher Federico Vaca, M.D., M.P.H, and his colleagues at the National Institutes of Health, and led by Colorado State University investigators.
Stroke victims can receive treatment up to 24 hours later
With stroke, timing is everything. And the time available to save patients from severe paralysis or worse has recently been extended so far that Dr. Charles Matouk, chief of neurovascular surgery at Yale New Haven, said it’s nothing short of a revolution in public health.
Gene sequencing at Yale finding personalized root of disease; new center opens in West Haven
Our genes define our individuality, including what diseases to which we may be susceptible. In just a few days, gene-sequencing machines can map all of a person’s genes, revealing the cause of a genetic illness and even suggesting the best possible treatment. On Monday, the Yale School of Medicine, partnering with Yale New Haven Hospital, took the next step toward personalized medicine, cutting the ribbon on its Center for Genome Analysis on Yale’s West Campus.